Zimbabwe has declined a significant US healthcare agreement valued at $367m (272 million pounds) spanning five years due to the United States' request for confidential data.
The decision became public after a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
An official representative later explained that the United States was requesting biological samples for scientific study and commercial gain but was not willing to share the resulting advantages from any future treatments.
"We are forced to start the challenging and unfortunate process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged continued negotiations to secure a deal agreeable to both sides so the country's critical HIV programme can continue.
Wider Implications
Zimbabwe's decision follows a comparable situation in neighbouring Kenya, where a court halted a similar deal with the US after concerns were raised about the safety of citizens' health data.
After resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing direct bilateral deals to enhance transparency and accountability.
According to statements, Sixteen African countries have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration would have delivered extraordinary benefits for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving HIV treatment via American-funded initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any corresponding promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," he stated.
"Put simply, our country would provide the basic resources for medical research with no assurance that the final treatments would be accessible to our population should a future disease outbreak emerge."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems already set up via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage future pandemics.
"This system is intended to ensure that when a country provides its data, the resulting advantages – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the funds to create them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future collaboration might be arranged in a manner that honours the sovereignty and interests of both nations."
Medical Community Response
Medical experts said it recognised the official position, but recommended that negotiations must proceed since much of the nation's Aids initiatives depended on foreign aid.
"Where specific concerns exist, such as those relating to data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," it said.
This impasse underscores the complex debate between accepting crucial foreign assistance and safeguarding a country's data in an increasingly data-driven world.